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Aneuploid yeast strains exhibit defects in cell 
growth and passage through START
Rebecca R. Thorburna,*, Christian Gonzaleza,*,†, Gloria A. Brarb, Stefan Christenc, 
Thomas M. Carlilea,‡, Nicholas T. Ingoliab,§, Uwe Sauerc, Jonathan S. Weissmanb, 
and Angelika Amona
aDavid H. Koch Institute for Integrative Cancer Research and Howard Hughes Medical Institute, Massachusetts 
Institute of Technology, Cambridge, MA 02139; bDepartment of Cellular and Molecular Pharmacology and Howard 
Hughes Medical Institute, University of California, San Francisco, and California Institute for Quantitative Biosciences, 
San Francisco, CA 94158; cInstitute of Molecular Systems Biology, Eidgenössische Technische Hochschule Zurich, 
8092 Zurich, Switzerland
ABSTRACT Aneuploidy, a chromosome content that is not a multiple of the haploid karyo-
type, is associated with reduced fitness in all organisms analyzed to date. In budding yeast 
aneuploidy causes cell proliferation defects, with many different aneuploid strains exhibiting 
a delay in G1, a cell cycle stage governed by extracellular cues, growth rate, and cell cycle 
events. Here we characterize this G1 delay. We show that 10 of 14 aneuploid yeast strains 
exhibit a growth defect during G1. Furthermore, 10 of 14 aneuploid strains display a cell 
cycle entry delay that correlates with the size of the additional chromosome. This cell cycle 
entry delay is due to a delayed accumulation of G1 cyclins that can be suppressed by supply-
ing cells with high levels of a G1 cyclin. Our results indicate that aneuploidy frequently inter-
feres with the ability of cells to grow and, as with many other cellular stresses, entry into the 
cell cycle.
INTRODUCTION
In most eukaryotes, the decision of whether or not to enter the cell 
cycle is made in G1 and governed by extracellular and intracellular 
cues (reviewed in Turner et al., 2012). Identifying and characterizing 
the pathways that regulate this decision is critical for understanding 
not only normal cell division, but also the abnormal cell divisions 
that are seen in cancer. The molecular events governing entry into 
the cell cycle—known as START—are well characterized in budding 
yeast (Jorgensen and Tyers, 2004). During early G1, the cyclin-
dependent kinase (CDK) Cdc28 is activated by the Cln3 cyclin sub-
unit in a manner that is intimately coordinated with growth rate and 
extracellular signals such as nutrient availability and the presence of 
mating pheromone (reviewed in Turner et al., 2012). In turn, Cln3-
CDKs regulate the transcriptional inhibitor Whi5. During G1, Whi5 
localizes to the nucleus, where it inhibits the SBF transcription factor 
complex (Costanzo et al., 2004; de Bruin et al., 2004). This complex 
(composed of Swi4 and Swi6) and a similar complex MBF (composed 
of Mbp1 and Swi6) activate the transcriptional program essential for 
DNA replication and bud formation (Futcher, 2002). Key among 
SBF’s targets are the two G1 cyclin-encoding genes CLN1 and CLN2 
(Cross et al., 1994; Stuart and Wittenberg, 1994). Cln1/2-CDKs trig-
ger S phase and budding.
Cln3-CDKs phosphorylate Whi5 (Costanzo et al., 2004; de Bruin 
et al., 2004), triggering nuclear export of this transcriptional inhibitor 
and allowing SBF-dependent transcription to begin and Cln1/2-
CDKs to accumulate. This sets in motion a positive feedback loop in 
which Cln1/2 CDKs further phosphorylate Whi5, promoting its nu-
clear export and hence SBF-meditated transcription of CLN1 and 
CLN2 (Skotheim et al., 2008). Once cells have accumulated enough 
Cln-CDK activity, proteins critical for bud formation and initiation of 
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mosomes II and V) and 12 strains that showed cell cycle entry delays 
after release from an α-factor arrest (strains disomic for chromo-
somes IV, VIII, X, XI, XII, XIII, XIV, XV, XVI, VIII + XIV, XI + XV, and 
XI + XVI; Supplemental Figure S1). Consistent with our previous 
studies (Torres et al., 2007), strains disomic for chromosomes II and 
V did not exhibit a cell cycle entry delay as judged by the time to 
bud formation after isolation of isovolumetric populations of wild-
type and disomic cells (Supplemental Figure S1, A and C). Cell cycle 
entry was delayed in all other disomic yeast strains tested, with de-
lays ranging from ∼5 min for disome XIII to ∼110 min for disome IV. 
We conclude that most of the disomic yeast strains tested are de-
layed in cell cycle entry.
Critical cell size is increased in many disomic strains
A delay in cell cycle entry can be caused by a cell cycle defect that 
culminates in a delay in the accumulation of Cln-CDK activity, slowed 
growth, or a combination of both. Cell cycle entry delays caused by 
defects in the cell cycle machinery promoting the G1–S transition 
result in an increase in critical cell size (Rupes, 2002). We found that 
10 of 14 aneuploid strains analyzed showed an increase in critical 
cell size, defined by the modal cell volume corresponding to half-
maximal budding (Figure 1, A–N, and Table 1). This increase in criti-
cal size ranged from 3 fl for disome VIII + XIV to 22 fl for disome 
XI + XV. Of interest, the increase in critical size correlates with the 
size of the additional chromosome (Figure 1O), suggesting that 
some aspect of aneuploidy proportional to the amount of additional 
genetic material contributes to the increase in critical size.
To determine whether the delay in cell cycle entry was propor-
tional to the amount of additional DNA or proportional to other 
factors dependent on chromosome size such as the amount of yeast 
gene products produced from the additional chromosomes, we ex-
amined the critical sizes of yeast strains containing human DNA car-
ried by yeast artificial chromosomes (YACs). We do not know whether 
transcription occurs from the human DNA; however, due to the fun-
damentally different splicing mechanisms in yeast and mammals, 
any mRNA produced from the YAC is likely to produce few, if any, 
functional gene products. This allowed us to examine the effect of 
excess chromosomal DNA on G1–S phase progression, without ex-
cess gene products.
Introduction of an 850-, 670-, or 620-kb YAC did not delay cell 
cycle entry as judged by budding (Figure 2). We conclude that ad-
ditional functional yeast chromosomes, but not chromosome-sized 
amounts of DNA that do not produce yeast gene products, cause 
an increase in critical size. This increase in critical size is proportional 
to the size of the additional chromosome and thus the amount of 
additional genes, as chromosomes in yeast are densely packed with 
genes.
Cell volume accumulation in G1 is slowed in aneuploid 
yeast strains
Following elutriated cells as they progress through G1 also al-
lowed us to assess the effects of disomy on cell growth during G1, 
monitored by cell volume accumulation. This was of interest be-
cause slow growth can delay entry into the cell cycle. For example, 
cells lacking Sfp1, a transcription factor required for ribosome bio-
genesis (Fingerman et al., 2003), exhibit a severe G1 delay 
(Jorgensen et al., 2002; Hoose et al., 2012). sfp1Δ cells obtained 
by centrifugal elutriation take a longer time to enter the cell cycle 
than wild-type cells as judged by bud formation (Supplemental 
Figure S2A; Jorgensen and Tyers, 2004; Hoose et al., 2012). Cell 
volume measurements during G1 show that sfp1Δ cells have a cell 
volume accumulation rate ∼50% of wild type when G1 time points 
DNA replication are phosphorylated, driving entry into the cell cycle 
(Bloom and Cross, 2007). Pathways parallel to CLN3 also promote 
entry into the cell cycle. BCK2 promotes passage through START in 
parallel to CLN3 by inducing CLN1/2 transcription by an unknown 
mechanism (Epstein and Cross, 1994; Di Como et al., 1995).
Activation of the Cln3-CDK cascade is controlled by macromol-
ecule biosynthesis rates (reviewed in Turner et al., 2012). Cell growth 
controls cell cycle progression by influencing the critical size, which 
is the volume at which cells enter the cell cycle (Rupes, 2002). In 
general, slow-growing cells enter the cell cycle at smaller volumes 
than cells growing at faster rates (Jorgensen and Tyers, 2004; 
Ferrezuelo et al., 2012). In other words, a higher growth rate leads 
to an increase in critical cell size. How growth rate controls the G1 
cell cycle machinery is poorly understood. So far, only one mecha-
nism—translational regulation of Cln3—has been described by 
which growth rate affects the G1 cell cycle machinery (Polymenis 
and Schmidt, 1997). However, additional mechanisms must exist 
that link growth rate to cell cycle entry, as the consequences of inter-
fering with this CLN3 regulatory mechanism are subtle (Polymenis 
and Schmidt, 1997). Whatever these additional mechanisms are, it is 
clear that Cln-CDKs must be the target, as modulating Cln-CDK ac-
tivity affects the critical cell size. For example, overexpression of any 
of the G1 cyclins (CLN1, CLN2, or CLN3) leads to a “small-cell” 
phenotype, whereas their deletion causes a “large-cell” phenotype 
(Tyers et al., 1992, 1993).
We previously constructed a series of haploid budding yeast 
strains that are disomic for one or two chromosomes (henceforth 
disomes; Torres et al., 2007). All strains were found to exhibit pro-
liferation defects compared with a wild-type strain. Analysis of 
cell cycle progression of aneuploid yeast strains released from a 
pheromone-induced G1 arrest showed that most disomes exhibit 
a delay in CLN2 expression and cell cycle entry (Torres et al., 
2007). Here we further characterize the defects underlying the 
G1 delay in these strains. We find that most of the disomes (10 of 
14) exhibit a growth defect during G1. Entry into the cell cycle is 
also delayed in 10 of 14 strains, resulting in an increase in critical 
cell size that correlates with the degree of aneuploidy. Our analy-
ses further show that a defect in G1 cyclin accumulation underlies 
the G1 delay of disomic strains, which can be suppressed by sup-
plying cells with high levels of CLN2. Our results indicate that 
aneuploidy causes a G1 delay in most strains analyzed by inter-
fering with cell growth and/or the activation of the Cln3-CDK 
cascade.
RESULTS
G1 is extended in most disomic yeast strains
The 20 disomic budding yeast strains we previously generated 
(Torres et al., 2007) share a number of phenotypes, prominent 
among them a delay in entry into S phase after release from an α-
factor pheromone-induced G1 arrest. Sixteen of 20 aneuploid yeast 
strains exhibited a delay in bud formation and initiation of DNA rep-
lication, ranging from 10 to 20 min (Torres et al., 2007). Treatment of 
cells with pheromone inhibits cell cycle progression, but cell growth 
continues, disrupting the coordination of cell growth and division. 
Thus pheromone block-release experiments do not allow one to 
determine whether cell growth or cell cycle entry (or both) is im-
paired in aneuploid yeast cells.
To characterize the effects of aneuploidy on cell growth and cell 
cycle entry, we isolated small, unbudded cells using centrifugal elu-
triation and examined their growth and cell cycle entry properties. 
We chose 2 aneuploid yeast strains for this analysis that did not ex-
hibit a G1 delay upon pheromone release (strains disomic for chro-
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increase of aneuploid and euploid cells during G1. We isolated 
small, unbudded cells using centrifugal elutriation and monitored 
cell volume as a function of time. Of the 14 aneuploid strains ana-
lyzed, we found that 10 exhibited a defect in volume accumulation 
(Figure 3 and Supplemental Figure S3). This is easily seen when size 
distributions of wild-type and aneuploid cells of the same volume 
(<20% budded) were fit to an exponential function and a critical 
size smaller than wild type, consistent with other reports (Supple-
mental Figure S2, B–D; Jorgensen et al., 2002; Hoose et al., 
2012).
To determine whether a growth defect contributes to the G1 
delay observed in aneuploid cells, we examined rates of volume 
FIGURE 1: Cells carrying an extra chromosome delay entry into the cell cycle by increasing the critical size for budding. 
Wild-type (A–N; A11311, filled circles) and disomes (open circles) II (A; A6865), IV (B; A12687), V (C; A14479), VIII 
(D; A13628), X (E; A21986), XI (F; A13771), XII (G; A12694), XIII (H; A21987), XIV (I; A13979), XV (J; A12697), XVI 
(K; A12700), XI + XV (L; A12691), XI + XVI (M; A12699), and VIII + XIV (N; A15615) were grown at 30°C in selective 
medium supplemented with 2% raffinose. Small, unbudded cells were isolated by centrifugal elutriation and released 
into the cell cycle at 30°C in YEPD. Time points were taken every 15 min to measure cell volume and the percentage of 
budded cells. (O) Correlation between the critical size for budding and the size of the extra chromosome in the disome. 
The critical size (shown as percentage of wild-type critical size for each experiment) is positively correlated with the size 
of the extra chromosome (r2 = 0.41, p = 0.019). Disome XII was excluded from the correlation analysis due to variations 
in ribosomal DNA copy number, which preclude determination of the exact chromosome size.
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Decreased growth rates in aneuploid cells are 
not due to gross amino acid biosynthesis defects
Our data show that aneuploid yeast strains exhibit both growth de-
fects and cell cycle entry delays. We decided to first characterize the 
growth defect in more detail. To determine whether the G1 growth 
defect was due to a lack of amino acids, we measured pools of free 
intracellular amino acids in aneuploid cells. We analyzed sfp1Δ cells 
for comparison, as this mutant is able to synthesize amino acids but 
grows slowly due to defects in ribosome biogenesis (Fingerman 
et al., 2003).
To measure intracellular amino acid pools, we grew cells in me-
dium supplemented with the essential amino acids for these strains 
(lysine, leucine, tryptophan, and methionine). Levels of the amino 
acids alanine, asparagine, aspartate, glycine, histidine, isoleucine, 
phenylalanine, proline, serine, threonine, tyrosine, and valine, as 
are compared with size distributions after growth in rich medium for 
60 min (Figure 3, B, D, F, and H).
To determine the growth rate during G1, we fit the plots of vol-
ume increase versus time to exponential functions, restricting this 
analysis to time points in which <20% of the cells in the population 
were budded. Growth rates were reduced in 10 of 14 aneuploid 
strains; this reduction is best observed when the growth rate is 
shown as a percentage of the wild-type control (Figure 3I and Table 
1). Three strains (disomes IV, XVI, and XI + XVI) showed growth rates 
of <75% of wild type (Figure 3I, red); seven strains (disomes V, VIII, 
XI, XII, XIII, XIV, and XI + XV) exhibited growth rates between 75 and 
90% of wild type (Figure 3I, yellow); and four strains (disomes II, X, 
XV, and VIII + XIV) grew as well as wild-type cells (Figure 3I, green). 
The decreases in growth rates of aneuploid strains were significant 
(p = 0.0007, paired Student’s t test); however, the extent of the 
growth defect did not correlate with the size of the additional chro-
mosome (Supplemental Figure S3K).
The growth properties of disome XVI cells are particularly nota-
ble, as the delay in bud formation observed in this strain is entirely 
due to a defect in cell volume accumulation. Critical cell size was 
not affected in disome XVI, yet budding was delayed for almost 
40 min (Table 1, Figure 1K, and Supplemental Figure S1K). Cell vol-
ume measurements showed that growth was impaired in disome 
XVI cells (Figure 3, G and H), providing an explanation for the delay 
in bud formation. It is possible that the additional copy of CLN2 
located on chromosome XVI masks any cell cycle defect, as G1 cy-
clin levels are rate limiting for cell cycle entry (Futcher, 1996). In 
summary, our results indicate that most aneuploid strains analyzed 
show a reduced growth rate in G1. In contrast to the increased criti-
cal size observed in aneuploid cells, the severity of the cell volume 
accumulation defect is not correlated with the amount of additional 
DNA (Supplemental Figure S3K). These findings suggest that gene-
specific effects, and not general features of aneuploidy, are respon-
sible for the cell volume accumulation defect seen in the disomic 
strains.
Strain Critical size (fl)a
Critical size, percentage 
of wild type
Exponential growth  
constant, k (min−1)a
Exponential growth 
constant, percentage of 
wild type
Dis II 35 (38) 92 0.006144 (0.005882) 104
Dis IV 53 (39) 136 0.004667 (0.006939) 67
Dis V 33 (40) 83 0.006101 (0.007391) 83
Dis VIII 46 (38) 121 0.006339 (0.007433) 85
Dis X 40 (35) 114 0.006894 (0.006931) 99
Dis XI 55 (40) 138 0.005967 (0.006944) 86
Dis XII 53 (38) 139 0.004160 (0.005239) 79
Dis XIII 40 (40) 100 0.004738 (0.005839) 81
Dis XIV 41 (36) 114 0.006343 (0.007126) 89
Dis XV 52 (39) 133 0.005213 (0.005098) 102
Dis XVI 36 (38) 95 0.005558 (0.007879) 71
Dis XI + XV 60 (38) 158 0.006480 (0.007471) 87
Dis XI + XVI 54 (37) 146 0.005835 (0.008001) 73
Dis VIII + XIV 42 (39) 108 0.006196 (0.006460) 96
Diploid 70 (38) — — —
aValues in parentheses are the haploid wild-type results for each experiment.
TABLE 1: Critical sizes and growth constants of disomic cells.
FIGURE 2: Yeast artificial chromosomes carrying human DNA do not 
cause an increase in critical size. Wild-type (A11311, filled circles), 
YAC-2 (A17392, 850 kb, open triangles), YAC-3 (A17393, 670 kb, open 
circles), and YAC-4 (A17394, 620 kb, open squares) cells were grown 
at 30°C in selective medium supplemented with 2% raffinose. Small, 
unbudded cells were isolated by centrifugal elutriation and released 
into the cell cycle at 30°C in YEPD. Time points were taken every 
15 min to measure cell volume and the percentage of budded cells.
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indicating that amino acid abundance (at least of the amino acids 
measured) was not affected in aneuploid strains. In fact, disome IV 
showed consistently higher levels of most amino acids (except 
well the intermediates of the TCA cycle, were quantified using 
time-of-flight mass spectrometry. Intracellular amino acid pools 
were not lower in disomic strain IV, VIII, XI, XV, or XVI (Figure 4), 
FIGURE 3: Cells carrying an extra chromosome show a decrease in growth rate during G1. (A–H) Wild-type (A–H; 
A11311, black), disome IV (A, B; A12687, red), disome XIV (C, D; A13979, red), disome XV (E, F; A12697, red), and 
disome XVI (G, H; A12700, red) cells were grown at 30°C in selective medium supplemented with 2% raffinose. Small, 
unbudded cells were isolated by centrifugal elutriation and released into the cell cycle at 30°C in YEPD. Time points 
were taken every 15 min to monitor cell volume. G1 time points (<20% budded cells in the population) were fitted to an 
exponential function to determine growth parameters. (B, D, F, H) Cell size distributions for elutriated wild-type (black) 
and disomic cells (red) of the same volume and after 1 h of growth in YEPD medium. (I) Distribution of growth constants 
for disomes II (A6865), IV (A12687), V (A14479), VIII (A13628), X (A21986), XI (A13771), XII (A12694), XIII (A21987), XIV 
(A13979), XV (A12697), XVI (A12700), XI + XV (A12691), XI + XVI (A12699), and VIII + XIV (A15615) are shown as the 
percentage of the wild-type (A11311) growth constant for each experiment. Disomes IV, XVI, and XI + XVI (red) show 
growth rates <75% of wild type; disomes V, VIII, XI, XII, XIII, XIV, and XI + XV (yellow) show growth rates 75–90% of wild 
type; and disomes II, X, XV, and VIII + XIV (green) show growth rates 90–110% of wild-type.
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tested (IV, VIII, XI, XV, and XVI) showed similar levels of LacZ activity 
to the euploid control (Supplemental Figure S4, gray bars). In the 
presence of 3-AT, disomic cells exhibited an increase in LacZ activity 
due to GCN4-LacZ translational up-regulation, consistent with the 
euploid control (Supplemental Figure S4, white bars). Therefore we 
conclude that the disomes analyzed do not exhibit a starvation re-
sponse under normal growth conditions and are not defective in 
eliciting a starvation response. Thus the slower growth rate seen in 
aneuploid cells is not the result of limiting amounts of amino acids 
but is likely due to decreased rates of biomass production.
Effects of disomy XVI on translation
Next we examined whether defects in translation are responsible for 
the growth defects observed in the disomic yeast strains. For this 
analysis we chose disome XVI, as this strain exhibits one of the most 
aspartate and isoleucine) and TCA cycle intermediates. Increased 
amino acid levels in disome IV cells may be related to the significant 
proliferation defect of this disome, as this phenotype is also seen in 
the sfp1Δ strain, which proliferates slowly (Figure 4R).
Consistent with the conclusion that free amino acids are not lim-
iting in aneuploid cells is the observation that aneuploid cells do not 
exhibit a starvation response (Supplemental Figure S4). GCN4 en-
codes a transcription factor that controls the expression of 30 amino 
acid biosynthetic genes (Hinnebusch, 2005). Its abundance is trans-
lationally regulated; upon amino acid starvation, GCN4 translation 
is increased (Hinnebusch, 2005). We monitored a GCN4-LacZ re-
porter construct (Hinnebusch, 1985) by LacZ activity in the absence 
or presence of amino acid starvation induced by the addition of 
3-amino-1,2,4-triazole (3-AT), a competitive inhibitor of an interme-
diate step in histidine synthesis. In the absence of 3-AT, all disomes 
FIGURE 4: Amino acids and organic acid levels are not altered in aneuploid cells. (A–R) Metabolomic analysis of 
wild-type (A11311), sfp1Δ (A3009), and disomes IV (A12687), VIII (A13628), XI (A13771), XV (A12697), and XVI (A12700). 
Cells were grown in synthetic medium supplemented with the necessary nutrients for growth (see Materials and 
Methods). Metabolites were extracted, separated by gas chromatography, and quantified by time-of-flight mass 
spectrometry. Error bars, SEM. n ≥ 5 for metabolites (A–Q), and n = 4 for doubling time (R). (S) Overview of TCA cycle.
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dramatic growth defects of the disomes yet does not show a 
cell cycle entry delay as judged by critical cell size measurements. 
Incorporation studies with [35S]methionine did not reveal any signifi-
cant differences between wild-type and disome XVI cells (data not 
shown), yet we were able to detect defects in [35S]methionine incor-
poration in sfp1Δ cells (data not shown), which exhibit a severe 
growth defect (Jorgensen et al., 2002; Hoose et al., 2012); Supple-
mental Figure S2). Although a decrease in growth rate of disome 
XVI was detected by cell volume measurements (Figure 3 and Table 
1), changes were not evident when translation was examined using 
polysome profiling (Figure 5A). These results indicate that this dis-
omic strain does not suffer from dramatic translation defects.
Because disome XVI cells did not show major translation defects 
by polysome profiling or [35S]methionine incorporation, we mea-
sured translation efficiency in this strain to determine whether trans-
lation efficiencies of individual genes were altered. Consistent with 
previous studies (Torres et al., 2007, 2010), we found that disome 
XVI cells have twice the amount of mRNA of genes located on chro-
mosome XVI as wild-type cells (Figure 5B), and these additional 
mRNAs are translated, as judged by their association with ribosomes 
(Figure 5C). Of importance, we observed no major shifts in relative 
translation efficiency between wild-type and disome XVI cells (Figure 
5D). In summary, our data indicate that many disomic yeast strains 
exhibit a subtle growth defect that is detected only by cell volume 
measurements. Given that all chromosomes are efficiently trans-
lated in disome XVI cells, we conclude that the decreased growth 
rate of this disome is not due to major translational defects or 
changes in translation efficiencies of individual genes.
Aneuploid cells exhibit delays in the transcriptional program 
governing the G1–S transition
Most disomic yeast strains are defective in cell cycle entry, having a 
cell volume larger than that of wild type at the time of budding 
(Figure 1 and Table 1). We next wanted to determine the basis for 
this defect. The genetic program governing entry into the cell cycle 
culminates in the expression of the G1 cyclins CLN1 and CLN2 
(Dirick et al., 1995). To determine whether the increased cell volume 
of disomic cells at the time of budding was due to a defect in cyclin 
expression, we examined CLN2 mRNA levels in disomes IV, XI, and 
XV, which have larger critical sizes than wild-type cells (Figure 1, B, F, 
and J). Small, unbudded cells were isolated by centrifugal elutria-
tion, and CLN2 mRNA levels were measured as a function of cell 
volume. These analyses showed that transcription of CLN2 occurred 
at a larger cell volume in the three disomic strains tested than in 
wild-type cells (Figure 6, A, B, and D). Maximal CLN2 transcription 
occurred at 42, 48–50, and 43 fl in disome IV, XI, and XV cells, re-
spectively, whereas CLN2 levels were maximal in wild-type cells at a 
size of 26–35 fl. We conclude that CLN2 transcription occurs at a 
larger cell volume in disome IV, XI, and XV strains. This finding is 
consistent with our previous studies of CLN2 expression in disomic 
strains released from a pheromone-induced G1 arrest, which also 
revealed delays in CLN2 transcription (Torres et al., 2007).
SBF and MBF, two transcription factor complexes with overlap-
ping specificities, control transcription of ∼200 genes important for 
FIGURE 5: Translational efficiency is not altered in disome XVI. 
(A) Polysome profiles of wild-type (A22361) and disome XVI (A12700) 
cells. (B–D) Analysis of translation in wild-type (A11311) and disome 
XVI (A12700) cells. (B) The log2 ratio of disome XVI to wild-type 
mRNA RPKM values is shown with the x-axis representing genes in 
rank order by chromosomal location. Genes included have 128 raw 
counts between the wild-type and disomic strains. (C) The log2 ratio 
of disome XVI to wild-type ribosome footprint RPKM values is shown 
with the x-axis representing genes in rank order by chromosomal 
location. Genes included have 128 raw counts between the wild-type 
and disomic strains. (D) Translation efficiency [TE = (ribosome 
footprint RPKM)/(mRNA RPKM)] was calculated for each gene with at 
least 128 summed raw counts between mRNA and footprints in both 
the disomic and wild-type strains. log2 TE values are represented as a 
histogram.
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MBF targets tested occurred at a larger cell volume in both disomic 
strains (Figure 6, C–H), suggesting that SBF and MBF activation is 
delayed in these aneuploid strains.
Xbp1 is a stress-induced transcriptional repressor that can inhibit 
transcription of G1 cyclins, delaying cell cycle entry under stressful 
conditions (Mai and Breeden, 1997, 2000). Deletion of XBP1 had no 
significant effect on the critical size of wild-type or disome VIII and 
XI cells (Supplemental Figure S5), suggesting that inhibition of cyclin 
expression by Xbp1 is not causing the G1 delay seen in the dis-
omes. We conclude that the SBF and MBF transcription program is 
delayed in disomic yeast cells, and this delay is not caused by Xbp1-
mediated inhibition of G1 cyclin expression.
The SBF and MBF transcriptional program is delayed, suggesting 
that aneuploidy interferes with the G1–S transition upstream of CLN2 
expression; however, this does not exclude the possibility of aneu-
ploidy also interfering with entry into S phase at a step following 
CLN1/2 expression. To address this possibility, we examined whether 
overexpression of CLN2, which is known to accelerate entry into the 
cell cycle (reviewed in Turner et al., 2012), suppresses the increase in 
critical size of cells disomic for chromosome IV, VIII, or XI. CLN2 was 
overexpressed from the galactose-inducible GAL1-10 promoter for 
1 h, and then small, unbudded cells were isolated by centrifugal elu-
triation. Because cells were grown in medium supplemented with 
raffinose and galactose as the carbon source, euploid cells express-
ing wild-type levels of CLN2 budded at a smaller critical size of 29 fl 
(Figure 7A). As expected, overexpression of CLN2 reduced the criti-
cal size of cells: wild-type cells overexpressing CLN2 exhibited a criti-
cal size of 22 fl (Figure 7B and Supplemental Table S1). Overexpres-
sion of CLN2 suppressed the cell cycle entry defect of disomes IV, 
events in late G1 and S phase (Ferrezuelo et al., 2010). SBF and MBF 
targets are cell cycle regulated, peaking at the G–S transition 
(Futcher, 2002). To determine whether the entire G1–S transcrip-
tional program was delayed in aneuploid cells with a G1 delay, we 
analyzed the expression of three SBF targets (CLN1, CLN2, and 
PCL1) and three MBF targets (POL1, CLB5, and RNR1) in disomes XI 
and XV as a function of cell volume. Peak expression of all SBF and 
FIGURE 6: Transcription of CLN2 and other SBF and MBF targets is 
delayed in disomes IV, XI, and XV. Disomic and wild-type cells were 
grown at 30°C in selective medium supplemented with 2% raffinose 
to mid–log phase. Small, unbudded cells were isolated by centrifugal 
elutriation and released into the cell cycle at 30°C in YEPD. Samples 
were taken to measure RNA levels and cell volume. (A, B) CLN2 RNA 
levels were examined in wild-type (A11311), disome IV (A12687), and 
disome XI (A13771) cells. ACT1 was used as a loading control. 
(B) Quantification of CLN2 levels in A normalized by ACT1. (C–H) RNA 
levels of the SBF targets CLN1 (C), CLN2 (D), and PCL1 (E) and of the 
MBF targets POL1 (F) RNR1 (G), and CLB5 (H) were determined by 
real-time reverse transcription-PCR in wild-type (C–H; A11311, filled 
circles), disome XI (C–H; A28266, open circles), and disome XV (C–H; 
A27930, open triangles). Transcript levels were normalized to ACT1 
levels. Dashed lines indicate the critical sizes (modal volume at 
half-maximum of budding) for each strain.
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FIGURE 7: Overexpression of CLN2 suppresses the critical size 
increase in disomes IV, VIII, and XI. Wild-type (B; A25475, filled circles), 
disome IV (B; A25477, open circles), disome VIII (B; A25476, open 
triangles), and disome XI (B; A25474, open squares) cells carrying a 
GAL-CLN2 construct and wild-type (A; A11311, filled circles), disome 
IV (A; A12687, open circles), disome VIII (A; A13628, open triangles), 
and disome XI (A; A13771, open squares) cells lacking the construct 
were grown to mid–log phase in selective medium supplemented with 
2% raffinose and induced for 1 h with 2% galactose. Small, unbudded 
cells were isolated by centrifugal elutriation and released at 30°C in 
YEP medium containing 2% galactose + 2% raffinose. Samples were 
taken every 15 min to determine cell volume and the percentage of 
budded cells.
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VIII, and XI (Figure 7B), with critical sizes of 19, 20, and 25 fl com-
pared with critical sizes of 34, 44, and 50 fl, respectively, for those not 
overexpressing CLN2. We conclude that the increase in critical size 
in aneuploid cells is due to a delay in CLN2 expression.
Whi5 nuclear exit is delayed in aneuploid cells
SBF, the transcription factor complex that promotes CLN1/2 expres-
sion, is composed of Swi4 and Swi6 and is negatively regulated by 
the transcriptional inhibitor Whi5. Whi5 binds to Swi4/6 at the pro-
moters of genes required for the G1–S transition, inhibiting tran-
scription (Costanzo et al., 2004; de Bruin et al., 2004). In G1, Cln3-
CDKs phosphorylate Whi5, promoting its export from the nucleus 
(Costanzo et al., 2004; de Bruin et al., 2004). In wild-type cells, 
Whi5–green fluorescent protein (GFP) exits the nucleus just before 
budding. In three disomes tested (IV, XI, and XV), Whi5-GFP protein 
levels were not dramatically altered and Whi5-GFP nuclear exit oc-
curred, as in wild type, just before budding (Figure 8). However, 
both budding and Whi5-GFP nuclear exit were delayed compared 
with the euploid control (Figure 8 and Supplemental Table S1). A 
fourth aneuploid strain, disome XVI, exhibits a growth defect but 
not a critical size increase (Figure 1K, Supplemental Figure S1K, and 
Table 1); as expected, Whi5 nuclear exit also occurred just before 
budding in this strain, and Whi5-GFP levels were not dramatically 
altered. We conclude that the relationship between Whi5 nuclear 
exit and budding is not altered in aneuploid cells; however, the en-
tire program of Whi5 nuclear exit, SBF/MBF activation, and budding 
is delayed in the disomic strains analyzed.
To further investigate the misregulation of START control in dis-
omic cells, we examined the consequences of WHI5 deletion in dis-
omes IV, VIII, and XI. The critical size of wild-type cells is 39 fl, but 
when WHI5 is deleted the critical size decreases to 30 fl (Figure 8F). 
Deletion of WHI5 did not suppress the critical size increase in aneu-
ploid cells; it affected wild-type and disomic cells similarly, decreas-
ing the critical size by 6–13 fl (Figure 8, F–I, and Supplemental Table 
S1). Taken together, our data indicate that the timing of Whi5 nu-
clear exit is delayed in the disomic strains analyzed, but time of bud-
ding is also perturbed through parallel pathways. Perhaps disomy 
IV, VIII, and XI interfere with the positive feedback loop regulating 
Whi5 nuclear export, alter SBF/MBF activity, or affect parallel 
pathways.
Accumulation of Cln3 is delayed in disome VIII and XI cells
Whi5 export from the nucleus is promoted by Cln3-CDKs. To deter-
mine whether lower Cln3 protein levels could be responsible for the 
delayed exit of Whi5 from the nucleus in the disomic yeast strains, 
we measured Cln3-13Myc levels in elutriated cells. Cln3 protein lev-
els fluctuated significantly during G1 in wild-type cells. Cln3 protein 
levels were low in small G1 cells, accumulated as cells reached a size 
of 21 fl, and declined shortly before cells entered the cell cycle 
(Figure 9A). This fluctuation in protein levels was not due to changes 
in CLN3 RNA levels (Figure 9A), indicating that posttranscriptional 
mechanisms are responsible for Cln3 protein fluctuations. The 
CLN3-13MYC allele is hypermorphic, causing a decrease in critical 
size from 38 to 31 fl in wild-type cells (Figure 9A). This is most likely 
because the C-terminal tag stabilizes the protein by interfering with 
degradation of Cln3, which is mediated by the PEST sequences 
FIGURE 8: Nuclear exit of Whi5 is delayed in disomes IV, XI, XV, and 
XVI, but deletion of WHI5 does not suppress the budding delay of 
disomes IV, VIII, and XI. (A–E) Wild-type (A; A25877), disome IV 
(B; A25879), disome XI (C; A31515), disome XV (D; A31516), and 
disome XVI (E; A25880) cells containing Whi5-GFP were grown at 
30°C in selective medium supplemented with 2% raffinose. Small, 
unbudded cells were isolated by centrifugal elutriation and released 
into the cell cycle at 30°C in YEPD. Time points were taken every 15 
min to monitor budding, Whi5-GFP localization, and cell volume. Bud, 
budding; Cyt, cytoplasmic Whi5. (F–I) Wild-type (F; A25479, open 
circles), disome IV (G; A25481, open circles), disome VIII (H; A25480, 
open circles), and disome XI (I; A25482, open circles) with WHI5 
deleted and wild-type (F; A11311, filled circles), disome IV (G; 
A12687, filled circles), disome VIII (H; A13628, filled circles), and 
disome XI (I; A13771, filled circles) cells with functional WHI5 were 
grown in selective medium supplemented with 2% raffinose. Small, 
unbudded cells were isolated by centrifugal elutriation and released 
at 30°C in YEPD. Time points were taken every 15 min to determine 
cell volume and the percentage of budded cells. (J) Wild-type 
(A25877), disome IV (A25879), disome XI (A31515), disome XV 
(A31516), and disome XVI (A25880) cells were grown at 30°C in YEPD, 
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and Whi5-GFP protein levels were detected by Western blot analysis. 
Disome XV (A31516) contains one copy of Whi5-GFP and one 
untagged copy of Whi5, as WHI5 is located on chromosome XV. 
Wild-type cycling cells (A2587) were used as a no-tag control.
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located in the C-terminus of the protein (Tyers et al., 1992). Thus the 
fluctuations in untagged Cln3 are likely to be, if anything, more 
dramatic.
Overall Cln3 levels were comparable between wild-type and di-
somic strains, but Cln3 protein levels peaked at a larger volume in 
both disome VIII and XI cells as compared with wild-type (Figure 9 
and Supplemental Figure S6). This finding indicates that Cln3 trans-
lation and/or stability is affected in these disomic strains. The effect 
of the CLN3-13MYC allele on the critical sizes of the two disomic 
yeast strains was variable. The basis of this variability is unclear 
(Figure 9B and Supplemental Figure S6A). We conclude that the 
delay of START in disome VIII and XI cells is due at least in part to a 
delay in the accumulation of Cln3 protein.
Aneuploidy impairs cell cycle entry in parallel to BCK2
Cln3-CDK activity is not essential for cell cycle entry, indicating that 
parallel pathways exist that activate Cln1/2-CDKs (Cross, 1988; Nash 
et al., 1988). Bck2 is one such factor; cells lacking BCK2 are large 
and exhibit a delay in CLN1 and CLN2 transcription (Di Como et al., 
1995). In addition, deletion of BCK2 causes lethality or severe 
growth retardation in cells lacking CLN3 (Epstein and Cross, 1994; 
Di Como et al., 1995). To determine whether aneuploidy interferes 
with cell cycle entry through BCK2, we examined the critical size of 
disomic cells lacking BCK2. If aneuploidy inhibits cell cycle entry 
through mechanisms that function in parallel to BCK2, we expect 
disomes lacking this gene to exhibit an increased critical size. If ane-
uploidy delays G1 by disrupting BCK2 function, the effects of com-
bining aneuploidy and a BCK2 deletion should not be additive.
Small, unbudded cells were isolated by centrifugal elutriation, 
and budding was measured as a function of volume. In wild-type 
cells, deletion of BCK2 caused an increase in critical size of ∼11% 
(Figure 10A and Supplemental Table S1). Deletion of BCK2 had a 
greater effect on the disomic strains than the wild-type strain, caus-
ing increases in critical size ranging from 29 to 46% in the disomes 
tested (Figure 10, B–E, and Supplemental Table S1). A greater in-
crease in critical size in the disomes upon deletion of BCK2 suggests 
that disomic strains depend more on the BCK2 pathway for cell cy-
cle entry than do wild-type cells. This conclusion is consistent with 
our data suggesting that the Cln3-CDK/Whi5/SBF pathway is im-
paired in disomic cells. Taken together, our results indicate that 
aneuploidy affects entry into the cell cycle in at least two ways: ane-
uploidy elicits a growth defect and causes a cell cycle entry delay 
that is due to a delay in Cln3 accumulation.
Many progeny of triploid meioses exhibit a G1 delay
The strategy we used to create the disomic yeast strains is limited in 
that only low-complexity aneuploidies (gains of one or two chromo-
somes) can be obtained (Torres et al., 2007). To determine whether 
yeast strains with more complex aneuploidies also exhibit a G1 de-
lay, we induced triploid strains to undergo meiosis. In such meioses 
progeny are generated with a range of karyotypes: haploid, diploid, 
and aneuploidies ranging from 1N + X to 2N − X. Nearly all aneu-
ploid strains created in this manner are highly unstable (Pavelka 
et al., 2010; St. Charles et al., 2010; Sheltzer et al., 2011), but, we 
reasoned, could be cultured for brief periods of time to determine 
whether they also exhibit a G1 delay.
The viability of spores obtained from triploid meioses was very 
low, as expected (Parry and Cox, 1970; St. Charles et al., 2010). The 
few colonies that did grow up exhibited a wide range of proliferation 
rates. On the basis of our previous studies, we assume that progeny 
obtained from these meioses with wild-type or near wild-type 
pro liferation rates are either euploid or harbor aneuploidies of 
FIGURE 9: Cln3 accumulation is delayed in disome XI. Wild-type (A,C; 
A33692) and disome XI (B,C; A33694) cells were grown at 30°C in 
selective medium supplemented with 2% raffinose. Small, unbudded 
cells were isolated by centrifugal elutriation and released into the cell 
cycle at 30°C in YEPD. Time points were taken every 15 min to 
determine the percentage of budded cells, cell volume, and Cln3 
protein levels. In separate experiments, wild type (A) and disome XI 
(B) were elutriated as described and samples were taken every 15 min 
to determine the percentage of budded cells, cell volume, and CLN3 
RNA levels by reverse transcription-PCR. CLN3 protein and RNA 
levels are presented as fold changes from the first time point and 
plotted as a function of cell volume to demonstrate that Cln3 protein 
but not CLN3 RNA levels fluctuate significantly during G1. Cln3 
protein levels were normalized to Pgk1, and CLN3 RNA levels were 
normalized to ACT1. Wild-type cycling cells (A2587) were used as a 
no-tag control for the Western blots. The arrow underneath the blot 
marks the critical size (cs). (C) Wild-type and disome XI Cln3 protein 
levels from the experiments in A and B were quantified and 
normalized to Pgk1 levels. The Western blot used for quantification is 
not shown. This analysis shows that overall Cln3 protein levels are 
comparable between wild-type and disome XI strains.
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DNA content analysis revealed that many of the progeny of trip-
loid meioses exhibit a G1 delay (Figure 11). This G1 delay correlated 
remarkably well with proliferation rates as observed by growth on 
solid medium (Figure 11). Spores 1-1–1-3 obtained from triploid 
parent 1 grew very well and exhibited a DNA content profile very 
similar to that of the parent (Figure 11, B–E). Spores 1-4–1-7 grew 
poorly and showed an increase in G1 cells (Figure 11, F–I). Similar 
results were obtained with progeny from triploid parent 2. The per-
centage of cells in G1 was very low in exponentially growing cultures 
of this strain, the reason for which is unknown. It was nevertheless 
evident that in the aneuploid progeny, the G1 delay correlated with 
growth ability. Spore 2-1 grew well and exhibited a cell cycle distri-
bution close to that of the parent (Figure 11K); cultures of spores 
that grew poorly (spores 2-2–2-6) showed an increase in G1 cells 
(Figure 11, L–P). We conclude that many aneuploid yeast strains 
obtained as offspring of triploid meioses also exhibit a G1 delay.
DISCUSSION
We investigated the basis of the G1 delay observed in many dis-
omic yeast strains to understand how aneuploidy alters the regula-
tory networks controlling the G1–S phase transition. Two aspects of 
G1 regulation appear to be affected: cell growth and entry into the 
cell cycle. Thus the disomic yeast strains are unique in that they 
grow slowly, and yet, unlike most slow-growing mutants, they must 
reach a larger critical size to pass through START.
Most of the disomic strains show a growth defect during G1 as 
measured by cell volume accumulation (Figure 3 and Supplemental 
Figure S3). This growth defect is not nearly as dramatic as that seen 
in mutants impaired in ribosome biogenesis or protein synthesis 
(Supplemental Figure S2; Jorgensen et al., 2002; Hoose et al., 2012), 
but nevertheless, the defect is readily observed by cell volume mea-
surements. However, it should be noted that we did not detect any 
defects in global protein synthesis as judged by polysome profiles 
or [35S]methionine incorporation (Figure 5A; C.G., unpublished ob-
servations). These observations raise the possibility that the disomic 
cells are defective in cell volume accumulation but not protein syn-
thesis, which would imply that these aneuploid cells must be denser 
than euploid cells. We favor the idea that the defect in cell volume 
accumulation reflects an overall defect in macromolecule biosynthe-
sis, but the defect is too subtle to be detected by methods such as 
[35S]methionine incorporation and polysome profiling.
Our investigation of the basis for the cell volume accumulation 
defect of the disomic yeast strains indicates that it does not stem 
from diminished amino acid pools (Figure 4) or a constitutively ac-
tive amino acid starvation response (Supplemental Figure S4) or 
from shifts in translation efficiency (Figure 5A). Instead, we propose 
that macromolecule biosynthesis and/or other aspects of cell growth 
are hampered in aneuploid cells. One explanation for this growth 
defect is that particular genes present on the additional 
chromosome(s) in aneuploid cells may be causing slow growth. For 
instance, additional copies of key regulators of growth processes 
such as macromolecule biosynthesis, vesicle fusion, protein sorting, 
and/or energy production could lead to a slowing of growth. In this 
scenario, the reason for the growth defect is different in each aneu-
ploid strain. It is also possible that slow growth is caused by a fea-
ture common to all aneuploidies, such as an increase in the number 
of gene products due to the extra chromosome(s). Previous studies 
showed the additional chromosomes to be actively transcribed and 
translated in the disomic strains (Torres et al., 2007, 2010). Therefore 
it is possible that an increased burden on the transcription and 
translation machinery hampers cell growth. This scenario predicts 
that the growth defect correlates with the amount of additional 
chromosomes with little effect on cell proliferation, such as chromo-
some I (Torres et al., 2007), whereas slow-growing progeny harbor 
aneuploidies of (presumably multiple) chromosomes that cause sig-
nificant growth impairment.
FIGURE 10: Deletion of BCK2 exacerbates the G1 delay in disomic 
yeast cells. Wild-type (A; A31519, open circles), disome VIII 
(B; A26163, open circles), disome XI (C; A26162, open circles), disome 
XV (D; A31520, open circles), and disome XVI (E; A26161, open 
circles) lacking BCK2 and wild-type (A; A11311, filled circles), disome 
VIII (B; A13628, filled circles), disome XI (C; A13771, filled circles), 
disome XV (D; A12697, filled circles), and disome XVI (E; A12700, 
filled circles) with functional BCK2 were grown at 30°C in selective 
medium supplemented with 2% raffinose. Small, unbudded cells were 
isolated by centrifugal elutriation and released into the cell cycle at 
30°C in YEPD. Time points were taken every 15 min to determine cell 
volume and the percentage of budded cells. Experiments for strains 
containing BCK2 are the same experiments as in Figure 1 and are 
shown here for comparison; strains were not run in parallel with the 
bck2Δ strains.
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The increase in critical size of all disomes analyzed (disomes IV, 3. 
VIII, and XI) is suppressed by high levels of CLN2 (Figure 7).
Whi5 exit from the nucleus was delayed in all disomes studied 4. 
(disomes IV, XI, and XV; Figure 8).
The accumulation of Cln3 is delayed in all disomes analyzed 5. 
(disomes VIII and XI; Figure 9 and Supplemental Figure S6).
If the detailed characterization of a subset of disomic strains is 
representative of all disomic strains exhibiting a cell cycle entry de-
fect, our data point toward Cln3 accumulation being affected by 
aneuploidy.
How does aneuploidy interfere with Cln3 accumulation and/or 
other aspects of cell cycle entry? Are these G1 processes affected 
by changes in copy number of specific proteins or features common 
to all disomies? Consistent with the former idea are the critical size 
increases observed in disomes VIII, XIV and VIII + XIV. Whereas the 
single disomes exhibit increases in critical size of 8 fl (disome VIII) 
translation that occurs in the disomes. This is not what we observe, 
as the growth defect in the disomes does not correlate with the size 
of the additional chromosome (Supplemental Figure S3K). There-
fore we favor the idea that imbalances in individual proteins critical 
for cell growth hamper cell volume accumulation in the disomic 
strains.
The delay in cell cycle entry (as judged by a delay in bud forma-
tion) observed in the disomes was more pronounced than the 
growth defect, which led us to investigate this phenotype in more 
detail. Of the 14 aneuploid strains studied, 10 showed increased 
critical size. The following observations points toward a common 
origin of the cell cycle entry defects observed in the disomes:
The cell cycle entry delay correlated with the size of the addi-1. 
tional chromosome (Figure 1 and Table 1).
All disomes analyzed, namely disomes IV, XI, and XV, exhibit a 2. 
delay in CLN2 mRNA accumulation (Figure 6, A, B, and D).
FIGURE 11: Progeny of triploid meioses exhibit a G1 delay. MATa/a/α (B; triploid parent 1, A6424) and MATa/α/α (J; 
triploid parent 2, A6425) cells were induced to sporulate, and tetrads were dissected. Individual colonies were picked 
after 1 wk and grown to exponential phase in YEPD medium to determine DNA content (C–I; A6424 progeny; K–P; 
A6425 progeny). FL2-H detection thresholds were adjusted for each strain so that the cell population was within the 
linear detection range of the instrument. Plus signs indicate proliferation rates on solid medium, with +++ representing 
proliferation rates close or equal to wild-type controls and fewer plus signs indicating poorer proliferation rates. A 
haploid strain (A2587) is shown in A.
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and 5 fl (disome XIV), the double disome shows only a 3-fl increase 
in critical size compared with wild-type cells (compare Figure 1, D, 
I, and N). This finding suggests that the cell cycle entry delay in the 
individual disomes is caused by a defined number of imbalanced 
gene products that can be suppressed by providing a surplus of 
gene products located on another chromosome. In this model, the 
correlation between increased critical size and size of the additional 
chromosome would be explained by genes affecting cell cycle entry 
being distributed more or less evenly across the yeast genome. 
Moriya et al. (2006) identified all yeast genes whose increased dos-
age affects cell proliferation. It will be interesting to determine which 
of these, when present at two copies, affect cell cycle entry.
Although single gene imbalances could contribute to the delay 
in cell cycle entry, our data also indicate that a response to a com-
mon feature of disomy is responsible for the cell cycle entry delay 
observed in many disomic strains. The critical size increase in the 
disomes correlates with the size of the additional chromosome 
(Figure 1O), and all disomes analyzed appear to show a similar 
defect in the molecular pathway governing START (see earlier 
discussion). An increase in the amount of DNA is not responsible for 
the G1 delay in the disomes, as YACs containing human DNA do 
not cause an increase in critical size. A previous study suggested 
that increasing the number of SBF-binding sites delays cell cycle 
entry because they titrate Cln3 molecules (Wang et al., 2009). We 
analyzed the distribution of SBF-binding sites in the yeast genome 
as published in Ferrezuelo et al. (2010) and found them to be evenly 
distributed across the genome (data not shown). It is thus possible 
that Cln3 titration by SBF-binding sites contributes to the G1 delay 
observed in the disomes. Whereas an increase in SBF-binding sites 
could contribute to the G1 delay in the disomes, our analyses point 
toward delayed Cln3 protein accumulation as the major defect in at 
least disomes VIII and XI. We do not know whether CLN3 translation 
and/or Cln3 stability is affected in the aneuploid strains. Protein syn-
thesis rates affect CLN3 translation (Polymenis and Schmidt, 1997), 
and so aneuploidy could, via its effects on macromolecule biosyn-
thesis, affect Cln3 synthesis. Aneuploidy could also affect Cln3 sta-
bility. Recently the two ubiquitin ligases SCF-Cdc4 and SCF-Grr1 
were identified as being responsible for regulating Cln3 stability 
(Landry et al., 2012). It will be interesting to determine whether ane-
uploidy affects Cln3 ubiquitination by these ligases.
Many stresses cause a G1 arrest or delay (Herrero et al., 2003). 
It was suggested that aneuploidy causes proteotoxic and energy 
stress in yeast and mouse cells (Torres et al., 2007, 2010; Tang 
et al., 2011). These or other stresses elicited by aneuploidy could 
elicit a transient G1 delay by interfering with Cln3 accumulation. 
Indeed, proteotoxic stress induced by heat shock causes a G1 de-
lay (Johnston and Singer, 1980), which, like the G1 delay seen in 
the disomic yeast strains, can be suppressed by CLN2 overexpres-
sion (Rowley et al., 1993). Whether and how aneuploidy and other 
cellular stresses antagonize Cln3 accumulation are important ques-
tions that remain to be addressed.
Is the G1 delay that we observe in many of the disomes also 
seen in other models of aneuploidy? Our study of the progeny of 
triploid meioses suggests that many of the poorly growing and thus 
presumably highly aneuploid yeast strains show a significant G1 de-
lay that is detectable in exponentially growing cells. A study of 
aneuploid fission yeast cells created by triploid meioses showed 
that these cells also exhibit a delay in G1 during germination (Niwa 
et al., 2006), but the cause of the G1 delay is not known. Mouse 
embryonic fibroblasts trisomic for chromosome 1, 13, 16, or 19 
(Williams et al., 2008) and trisomy 21 human fibroblasts (Segal and 
McCoy, 1974) exhibit cell proliferation defects, but the basis of this 
proliferation defect has not been explored. Thus whether a con-
served effect on cell cycle entry exists in aneuploid cells of different 
species remains to be established. However, a common transcrip-
tional response reminiscent of the budding yeast environmental 
stress response (indicative of cellular stress and slowed prolifera-
tion) is observed in aneuploid yeast, Arabidopsis, mouse, and hu-
man cells (Sheltzer et al., 2012). It is tempting to speculate that 
aneuploidy, like many other cellular stresses, affects cell prolifera-
tion by delaying cells in G1. Determining the molecular mechanisms 
underlying the effects of aneuploidy on progression through G1 will 
be an important aspect of understanding how aneuploidy affects 
cell physiology.
MATERIALS AND METHODS
Yeast strains, plasmids, and growth conditions
All yeast strains are derivatives of W303 and are described in Sup-
plemental Table S2. Yeast strains were generated and manipulated 
as described previously (Guthrie and Fink, 1991). The GCN4-LacZ 
construct (Hinnebusch, 1985) was integrated at the URA3 locus. 
Cells were grown at 30°C in yeast extract/peptone (YEP) or in 
synthetic medium containing G418 at 0.2 mg/ml, supplemented 
with 2% raffinose, 2% raffinose plus 2% galactose, or 2% glucose 
(YEPD).
Elutriation
Cells were grown in 1–2 l of synthetic medium supplemented with 
2% raffinose at 30°C. Cells were collected by centrifugation and re-
suspended in 30 ml of YEP without sugar. Cells were sonicated to 
break clumps and kept at 4°C for the duration of the elutriation. A 
Beckman elutriation rotor JE 5.0 (Beckman Coulter, Brea, CA) was 
chilled to 4°C and equilibrated with YEP (no sugar) at 2400 rpm. 
Cells were loaded into the rotor at a pump speed of ∼14 ml/min and 
allowed to equilibrate for 15–20 min at a rotor speed of 2400 rpm 
and a pump speed of ∼14 ml/min. The pump speed was increased 
until small, unbudded cells exited the elutriation chamber. One liter 
was collected at that pump speed (∼20 ml/min for most strains). 
Pump speed settings varied slightly among experiments, as the 
disomic strains have different cell volumes. Elutriated cells were 
concentrated using a filtration apparatus and resuspended in YEPD 
at 30°C.
Cell volume determination
Cell volume was measured using a Beckman Coulter Multisizer 3 
(Beckman Coulter). Approximately 50 μl of culture was diluted into 
Isoton II solution (Beckman Coulter) to give <10% saturation. Fifty 
thousand particles were sized for each sample. Particles <2 μm in 
diameter were excluded to decrease background signal and de-
crease the chances of counting dead cells. Cell volume distributions 
were smoothed with a rolling window of three bins. Modal popula-
tion values were used for the plots. The critical size of a strain is 
defined as the modal cell volume at half-maximal budding.
Ribosome profiling and mRNA-Seq
Ribosome profiling was performed as described (Ingolia et al., 
2009), with subtraction of three prominent rRNA species performed 
as in Brar et al. (2012). In short, cells were treated with 100 μg/ml 
cycloheximide to freeze ribosomes, then flash-frozen and subjected 
to mixer-mill lysis. Clarified extract was treated with RNase I and 
subjected to sucrose gradient fractionation. The 80S/monosome 
fraction was harvested and RNA was extracted and size selected for 
ribosome footprints (28–30 nucleotides [nt]). These footprints were 
converted into a sequencing library, which was sequenced using an 
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intermediate step in histidine synthesis, to a final concentration of 
100 mM.
Northern blot analysis
Cells were grown at 30°C in synthetic medium supplemented 
with 2% raffinose, elutriated as described, and released into the 
cell cycle. Time points were taken until after the critical size had 
been reached. Total RNA was isolated as described (Cross and 
Tinkelenberg, 1991), and Northern blots were performed as de-
scribed (Hochwagen et al., 2005). Blots were probed for CLN2 
and the loading control ACT1.
Real-time reverse transcription-PCR
Approximately 2–4 OD600 units of culture were pelleted by centrifu-
gation at 4°C (3000 rpm, 2 min). The pellet was resuspended in 1 ml 
of cold diethylpyrocarbonate (DEPC)-treated water, transferred to a 
2-ml microfuge tube, and repelleted by centrifugation at 4°C 
(3000 rpm, 2 min). The pellet was flash-frozen in liquid nitrogen and 
stored at −80°C. To extract total RNA, ∼200 μl of glass beads, 400 μl 
of TES buffer (10 mM Tris, pH 7.5, 10 mM EDTA, 0.5% SDS), and 
400 μl of acid phenol:chloroform (pH 4.5) were added to the cell 
pellet, and the tubes were vortexed for 45 min at 65°C. The phases 
were separated by centrifugation, and the top phase was transferred 
to a new tube containing 1 ml of 120 mM sodium acetate in ethanol 
to precipitate RNA at 4°C. Precipitates were collected by centrifuga-
tion and resuspended in 100 μl of DEPC-treated water. Total RNA 
was further purified using the RNeasy Mini Kit (Qiagen, Hilden, 
Germany), including DNase treatment, according to the manufac-
turer’s instructions. cDNA was synthesized from 750 ng of total RNA 
using the SuperScript III First-Strand Synthesis SuperMix Kit (Invitro-
gen, Grand Island, NY) with random hexamer primers according to 
the manufacturer’s instructions. Real-time quantitative PCRs were 
run using the SYBR Premix Ex Taq Perfect Real Time Kit (TaKaRa Bio, 
Otsu, Japan) and a Roche LightCycler 480 (Roche, Penzberg, 
Germany) according to manufacturer’s instructions. Quantitative 
PCR primers are listed in Supplemental Table S3.
Western blot analysis
Approximately 2–4 OD600 units of culture were pelleted by centrifu-
gation at 4°C (3000 rpm, 2 min). Cells were incubated at 4°C in 5% 
trichloroacetic acid for at least 10 min. Cell pellets were washed 
once with acetone and dried. Cells were lysed with glass beads in 
100 μl of lysis buffer (50 mM Tris-Cl at pH 7.5, 1 mM EDTA, 2.75 mM 
DTT, complete protease inhibitor cocktail [Roche, Mannheim, 
Germany]) with a bead mill, and samples were boiled in 1× SDS 
loading buffer. After SDS–PAGE and transfer of proteins to a nitro-
cellulose membrane, proteins were detected with the following an-
tibodies. Whi5-GFP was detected using a mouse anti-GFP antibody 
(JL-8 epitope; Clontech, Mountain View, CA) at a dilution of 1:1000. 
Cln3-13Myc was detected using a mouse anti-Myc antibody (9e10 
epitope; Covance, Princeton, NJ) at a dilution of 1:600. Pgk1 was 
detected using a mouse anti-Pgk1 antibody (Invitrogen, Carlsbad, 
CA) at a 1:10,000 dilution. Kar2 was detected using a rabbit anti-Kar2 
antibody (kindly provided by M.D. Rose, Princeton University, 
Princeton, NJ) at a dilution of 1:400,000. Quantification was 
performed using ImageQuant software.
Fluorescence microscopy
For Whi5-GFP imaging, cells were fixed in 4% paraformalde-
hyde/3.4% sucrose for 15 min and then resuspended in 0.1 M po-
tassium phosphate (KPi, pH 6.4)/1.2 M sorbitol/1% Triton. Cells were 
then resuspended in 0.05 μg/ml 4′,6-diamidino-2-phenylindole in 
Illumina GAII machine (Illumina, San Diego, CA). Sequences were 
aligned to the W303 genome and quantified as described (Ingolia 
et al., 2009). For translation efficiency (TE) analyses, calculations 
were only done on genes with 128 summed counts among mRNA 
and footprint samples, with TE = (ribosome footprint RPKM)/(mRNA 
RPKM), where RPKM is reads per kilobase million, a normalizing unit 
for gene length and total sequencing counts per lane. mRNA-Seq 
was also performed as described (Ingolia et al., 2009). In short, 
flash-frozen cells were lysed in hot acid phenol, and total RNA was 
extracted. A polyA selection was performed to isolate mRNA, which 
was fragmented to 40- to 60-nt species, which were converted into 
a sequencing library, sequenced, and analyzed in parallel with ribo-
some footprint samples.
Polyribosome profile analysis
Polysomes were prepared as described (Clarkson et al., 2010). 
Briefly, 250-ml cultures were grown in YEPD at 30°C to an OD600 of 
0.5. Cycloheximide was added to a final concentration of 0.1 mg/ml 
for 3 min. Cells were pelleted by centrifugation and lysed by vortex-
ing with zirconia/silica beads in 1× PLB (20 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid–KOH, pH 7.4, 2 mM magnesium 
acetate, 100 mM potassium acetate, 0.1 mg/ml cycloheximide, 
3 mM dithiothreitol [DTT]) and treated with RNasin Plus RNase in-
hibitor (Promega, Fitchburg, WI). Lysates were clarified by centrifu-
gation, and 25 A260 units were resolved on 11-ml linear 10–50% 
sucrose gradients in 1× PLB by centrifugation in a Beckman SW41 
rotor (Beckman Coulter) for 3 h at 35,000 rpm.
Metabolomic analysis
All strains were grown in shake flasks at 30°C and 250 rpm in de-
fined minimal medium containing the following per liter (adapted 
from Verduyn et al., 1992): 5 g of KH2PO4, 0.5 g of MgSO4•7H2O, 2 g 
of monosodium glutamate, 1.5 mg of EDTA, 4.5 mg of ZnSO4•7H2O, 
0.3 mg of CoCl2, 1 mg of MnCl2•4H2O, 0.3 mg of CuSO4•5H2O, 
4.5 mg of CaCl2•2H2O, 3 mg of FeSO4•7H2O, 0.4 mg of 
NaMoO4•2H2O, 1 mg of H3BO3, and 0.1 mg of KI. Filter-sterilized 
vitamins were added separately to a final concentration per liter of 
the following: 0.005 mg of biotin, 0.1 mg of Ca-pantothenate, 
0.1 mg of nicotinic acid, 2.5 mg of inositol, 0.1 mg of pyridoxine, 
0.02 mg of p-aminobenzoic acid, and 0.1 mg of thiamine. The me-
dium was buffered with 100 mM KH-phthalate at a pH of 5. Owing 
to the genetic markers in the strains, the medium was supplemented 
with the following compounds per liter: 0.031 g of lysine, 0.02 g of 
uracil, 0.24 g of leucine, 0.08 g of adenine, 0.02 g of tryptophan, 
0.021 g of methionine, and 0.2 g of geneticin (G418). Cells were 
grown to an OD600 between 0.7 and 1.5 when metabolism of 1 ml 
of culture was arrested by quenching in −40°C methanol plus 10 mM 
ammonium acetate. After centrifugation at −9°C (3 min, 5000 rpm) 
the samples were stored at −80°C. Intracellular metabolites were 
extracted by incubation in 75% ethanol plus 10 mM ammonium ac-
etate for 3 min at 80°C. The supernatant was dried using a vacuum 
centrifuge. The dried extracts were derivatized with N-tert-butyldi-
methylsilyl-N-methyltrifluoroacetamide for quantification. The me-
tabolites were separated by gas chromatography and injected into 
a time-of-flight mass spectrometer as described in Ewald et al. 
(2009).
β-Galactosidase activity assay
Cell extracts and activity measurements were performed as de-
scribed (Dever, 1997). Cells were grown in synthetic medium lacking 
histidine and supplemented with 2% glucose. Amino acid starvation 
was induced by the addition of 3-AT, a competitive inhibitor of an 
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